Oct 22 – Chinaccelerator Daily Digest: Five Headlines you need to know
1. Cell therapy pioneer Dr. Carl June to chair Nanjing Bioheng Biotech, a CAR-T startup led by former postdoc at June’s UPenn lab, pursuing off-the-shelf approach with CRISPR flavor. Endpoint
2. Sinotau Pharmaceutical Group completes $50 million Series D+ for clinical R&D of new radioactive drugs. Pandaily
3. US-China biopharma firm ShouTi lands $100M Series B to turn injected medicines into oral pills, solving logistical challenges such as cold storage. Co-founded by Schrödinger, a company whose software is used by many life-science companies for drug research, ShouTi designs small molecules intended to do the work of biologics. MedCity
4. Laxcen Technology completes $27M Series C to develop computer chips, IoT and smart-terminal businesses. Pandaily
5. Alibaba’s Taobao had a 20-minute system breakdown as presales for Singles’ Day festival kick off. SCMP
Goama is looking for a Partnership & Growth Manager. https://chinaccelerator.com/jobs/partnership-growth-manager-goama/